(Q36758843)

16 August 2017

1 reference

title

Panitumumab: a fully human monoclonal antibody with activity in metastatic colorectal cancer (English)

1 reference

16 August 2017

1 reference

1 reference

Claire E Saadeh

1

1 reference

16 August 2017

H Stephen Lee

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

13 March 2007

1 reference

Annals of Pharmacotherapy

16 August 2017

1 reference

16 August 2017

41

1 reference

16 August 2017

4

1 reference

16 August 2017

606-613

1 reference

Systemic therapy for colorectal cancer

16 August 2017

1 reference

Systemic therapy for metastatic colorectal cancer: current options, current evidence

21 January 2018

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

21 January 2018

1 reference

Therapeutic potential of ABX-EGF: a fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment

21 January 2018

1 reference

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

21 January 2018

1 reference

Targeting signal transduction pathways in colorectal cancer--more than skin deep

21 January 2018

1 reference

The EGF receptor family as targets for cancer therapy

21 January 2018

1 reference

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

Clinical implications of the mechanism of epidermal growth factor receptor inhibitors

21 January 2018

1 reference

Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody

21 January 2018

1 reference

Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer

21 January 2018

1 reference

A phase III randomized, open-label, controlled trial of chemotherapy and bevacizumab with or without panitumumab in the first-line treatment of patients with metastatic colorectal cancer.

21 January 2018

1 reference

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1H492

1 reference

release_36rgttptmfhm5jf7dujcniezii

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/36rgttptmfhm5jf7dujcniezii

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference